Evo Fund lowers stake in Delta-Fly Pharma to 20.65%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2026-10-07 11:06 JST concerning Delta-Fly Pharma, Inc. Reported holding ratio: 20.65%, previous report: 22.71%.